PreciseType(TM) HEA Test Recognized in The Scientist's Top 10 Innovations of 2014

NORCROSS, Ga., Dec. 1, 2014 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, announced that its PreciseType HEA test, the first and only FDA-approved molecular immunohematology assay, has been named a Top Innovation in The Scientist's Top 10 Innovations of 2014 – an annual competition in which the publication highlights the newest laboratory products that are set to revolutionize life sciences.

"We are honored to be included in an impressive list of innovations that share a mission to advance life sciences," said William A. Hawkins, President and Chief Executive Officer of Immucor. "FDA approval of our PreciseType HEA test is only our first step in providing diagnostics that enable personalized medicine, thereby raising the standard of care in transfusion medicine. With advancements in our molecular portfolio on the horizon, we look forward to providing more innovative diagnostics that can be used to provide the closest match possible in transfusion applications."

The PreciseType HEA test is a molecular assay that identifies 35 red blood cell antigens from 11 blood groups simultaneously. Consolidation of antigen identification into one test enables clinicians and blood banks to efficiently perform a more detailed, extended typing of patients and donors, allowing increased transfusion compatibility. The results reduce the risk of alloimmunization and serious hemolytic reactions. The PreciseType test also provides valuable information in blood donation centers for improved donor management by identifying donors with rare or unusual antigens so blood banks can distinguish and save scarce units for special cases.

Click here to view a summary of the products earning spots in The Scientist's Top 10 Innovations.

About Immucor, Inc.

Founded in 1982, Immucor is a global leader in transfusion and transplantation diagnostics that facilitate patient-donor compatibility. Our mission is to ensure that patients in need of blood, organs, or stem cells get the right match that is safe, accessible, and affordable. With the right match, we can transform a life together. To learn more, visit

About The Scientist

The Scientist is for life science professionals—a publication dedicated to covering a wide range of topics central to the study of cell and molecular biology, genetics, neuroscience, and other life-science fields. We provide print and online coverage of the latest developments in the life sciences including trends in research, new technology, news, business, and careers. It is read by leading researchers in industry and academia who value penetrating analyses and broad perspectives on life-science topics both within and beyond their areas of expertise. Written by prominent scientists and professional journalists, articles in The Scientist are concise, accurate, accessible, and entertaining. To learn more, visit

CONTACT: Michele Howard 770.441.2051Source:Immucor, Inc.